Cancer Survivors Have High Prevalence of Chronic Pain
Prevalence higher for those with less than high school education, low income, public insurance
Cancer Pain
Mouthwashes Show Promise in Reducing Chemo-Related Oral Mucositis Pain
Two separate oral rinses were found to reduce pain from oral mucositis and mouth sores in patients receiving radiation therapy for head and neck cancers when compared to placebo.
Risks Associated With Transmucosal IR Fentanyls: Assessing the FDA Mitigation Strategy
Pharmacists, prescribers, and patients tend to have adequate knowledge of transmucosal immediate-release fentanyls for use in breakthrough cancer pain.
Managing Cancer Pain: Assessing the Risk for Nonmedical Opioid Use
Prescribing opioids for cancer pain should not be automatic. Patients and their families still need to be screened for abuse potential. Clinicians should consider analgesic options beyond opioids.
Giving the Choice of Medical Support During Painful Procedures to Children With Cancer
Children with cancer who were asked to choose the type of medical support received during invasive procedures were found to be empowered and to experience reduced levels of distress.
Reducing the Reliance on Opioids for Cancer Pain: Is the Switch to Cannabis a Viable Option?
Articles discussing the use of cannabis as a substitute for opioids highlight the limitations of the existing scientific evidence in the field.
AI-Based Smartphone App Can Help Cut Cancer Pain Severity
An artificial intelligence (AI)-based smartphone app can reduce the severity of cancer patients’ reported pain and hospital admissions.
Smartphone App Improves Management of Cancer-Related Pain, Anxiety
Artificial intelligence and mobile technology combined in a smartphone app demonstrated an ability to accurately measure and respond to urgency of patients’ pain.
Pain Management Index Scores May Not Be Indicative of Treatment Success
Pain Management Index scores were found to be inversely associated with the percentage of patients who experience pain interference.
Polymorphisms Associated With Higher Opioid Requirements in Advanced Cancer
Two single nucleotide polymorphisms in the gene encoding for TAO kinase 3 were found to be associated with higher opioid dose requirements in patients with cancer pain.
Next post in Cancer Pain
